Entry level $17.50 = Target price $20 = Stop loss $16.75 High short interest of 14.45% Stock is well below its average analyst price target @$29.11.& buy rating.
Company profile Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.